Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1999-09-22
2000-12-26
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 14, 530356, A61K 3839
Patent
active
061659835
ABSTRACT:
The invention relates to the use of collagen for the production of a drug for the treatment of degenerative articular processes. An injection suspension is preferably produced, which contains collagen and possibly a local anaesthetic. This injection suspension is applied into the affected joints by means of an injection.
REFERENCES:
patent: 3683076 (1972-08-01), Rovati
patent: 3966908 (1976-06-01), Balassa
patent: 4424208 (1984-01-01), Wallace et al.
patent: 4473551 (1984-09-01), Schinitsky
patent: 4582640 (1986-04-01), Smestad et al.
patent: 4704273 (1987-11-01), McMichael
patent: 4804745 (1989-02-01), Koepff et al.
patent: 4883864 (1989-11-01), Scholz
patent: 5002071 (1991-03-01), Harrell
patent: 5035056 (1991-07-01), Kludas
patent: 5137875 (1992-08-01), Tsunenaga et al.
patent: 5206023 (1993-04-01), Hunziker
patent: 5639796 (1997-06-01), Lee
Buvardi ed. (1989). The Merck Index. Merck & Co. Inc.: Rathway, NJ., p. 4353.
Carron. (1978). "Relieving pain with nerve blocks," Geriatrics 33(4):49-57.
Hernandez et al. (1988). "The immune response of guinea-pigs to type II collagen: poor cross-reactivity with homologous type II collagen accounts for resistance to collagen-induced arthritis," Immunol. 63:619-624.
Moya (1981). "Treatment of osteoarthritis of the spine and herpetic neuralgia at the Pain Center, Mount Sinai Medical Center," NIDA Res. Monogr. Ser. 36:118-121.
Myers et al. (1989). "A CD4 cell is capable of transferring suppression of collagen-induced arthritis," J. Immunol. 143(2):3976-3980.
Stedman's Medical Dictionary. (1982). 24th Edition, Williams & Wilkins: Baltimore, MD., p. 271.
Steffen et al. (1975). "Collagen-induced acute synovitis in collagen-immunized rabbits," Z Immunitatsforsch Exp Klin Immunol. 150(3):432-446.
Steffen et al. (1978). "Acute autoimmune collagen-induced arthritis in rabbits," Z. Rheumatol. 37:275-285.
Thorp et al. (1992). "Type II collagen-immune complex arthritis in sheep: collagen antibodies in serum, synovial fluid and afferent lymph," Clin. Exp. Rheumatol. 10:143-150.
Trentham et al. (1977). "Autoimmunity to type II collagen an experimental model of arthritis," J. Exp. Med. 146:857-867.
Volodina et al. (1991). "Collagen of human cartilage in deforming arthrosis," Ukr. Biokhim Zhurn. 63(4):47-51 (English translation attached) .
LandOfFree
Use of collagen for the treatment of degenerative articular proc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of collagen for the treatment of degenerative articular proc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of collagen for the treatment of degenerative articular proc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-994898